Atlas Venture Life Science Advisors »

Q32 Bio shares owned by Atlas Venture Life Science Advisors

Quarter-by-quarter ownership of Q32 Bio shares owned by Atlas Venture Life Science Advisors from 13F filings

Historical chart of Atlas Venture Life Science Advisors investment in Q32 Bio

Tip: Access up to 7 years of quarterly data

All positions including Q32 Bio held by Atlas Venture Life Science Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Q32 Bio by Atlas Venture Life Science Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $36M 2.1M 17.04

More positions owned by Atlas Venture Life Science Advisors

Dyne Therapeutics Common Stock (DYN)
Kymera Therapeutics Common Stock (KYMR)
Disc Medicine Common Stock (IRON)
Day One Biopharmaceuticals Common Stock (DAWN)
Third Harmonic Bio Common Stock (THRD)
Korro Bio Common Stock (KRRO)
Aerovate Therapeutics Common Stock (AVTE)
Q32 Bio Common Stock
Generation Bio Common Stock (GBIO)
Vigil Neuroscience Common Stock (VIGL)
Replimune Group Common Stock (REPL)
Ikena Oncology Common Stock (IKNA)
AvroBio Common Stock (AVRO)
Dianthus Therapeutics Common Stock (DNTH)
Xilio Therapeutics Common Stock (XLO)

View all positions for Atlas Venture Life Science Advisors

Top funds holding Q32 Bio

OrbiMed Advisors
Atlas Venture Life Science Advisors
Carlyle
Vivo Capital
Arch Venture Corp
5AM Venture Management
ADAR1 Capital Management
Platinum Investment Mangement
Vanguard Group
Exome Asset Management
BlackRock
Ensign Peak Advisors
BML Capital Management
Ikarian Capital
Geode Capital Management

View all funds holding Q32 Bio